IFA
12.9.2019 11:59:07 CEST | Business Wire | Press release
IFA Berlin has turned out to be another huge success story with nearly 2,000 exhibitors, 245,000 visitors, and a new all-time high for international attendance, with more than 50 percent of trade visitors coming from abroad. Three big technology trends dominated IFA across both consumer electronics and home appliances: voice, artificial intelligence and connectivity, especially given the rapid roll-out of high-speed, high bandwidth 5G mobile networks.
Two IFA Keynotes – by Huawei CEO Richard Yu and Qualcomm President Cristiano Amon - focused on how 5G-connectivity can push the power of artificial intelligence to the very edge of computing – in the devices, into vehicles and into industrial applications.
Anthony Wood , the CEO of Roku – which powers one third of all set-top boxes in the United States – used his keynote to outline his vision of how online streaming will dominate the TV experience, and announced his company’s expansion to the UK, with plans to move to other European countries as well. Hakan Bulgurlu , the CEO of Arçelik, dedicated his keynote to demanding industry action against climate change and plastic waste.
IFA’s innovation hub – IFA NEXT – also set new records with more start-ups and innovation leaders than ever spread across two halls, alongside research institutes from countries like Germany, Japan and Korea. This year, IFA NEXT hosted Japan as its first Global Innovation Partner country; the Japan pavilion was showcasing the newest ideas and innovations for how machines and humans can interact.
Keita Nishiyama , Director General of Commerce and Information Policy - Bureau, Ministry of Economy, Trade and Industry says "We hope that Japan’s Interface with Consideration and Sensibility has inspired IFA visitors to embrace the future and continue on the path of innovation. As the first partner country of IFA NEXT - we look forward to staying in touch with you. Please follow us as Ninja does!”
Once again, IFA Berlin lived up to its reputation as the world’s most important trade show for consumer electronics and home appliance.
"As an important driving force for trade and industry and the world's most important platform for consumer electronics and home appliances, IFA 2019 met the high expectations. With its large number of innovations, it has a positive influence on the mood in the international markets. With an unexpectedly stable high order volume in regard to the current market situation, the foundation was laid for a successful year-end business," explains Hans-Joachim Kamp , Chairman of the Supervisory Board of IFA organizer gfu Consumer & Home Electronics.
"We are satisfied with the results of IFA 2019. Accordingly, the household appliance industry is optimistic about the future. This year too, IFA has strengthened its position as the world's significant trade show for home appliances and made a positive contribution to the market development," states Dr. Reinhard Zinkann , Chairman of the ZVEI.
The CEO of Messe Berlin, Dr. Christian Göke says IFA had once again shown the "power of co-innovation, where inventors in different sectors and industries inspire each other." He warned that trade wars, trade barriers and political barriers would harm consumers not just by making products more expensive, but by slowing down innovation itself. Picking up a theme developed in one of IFA’s most famous keynotes, by Albert Einstein in 1930, Dr. Göke said that in today’s day and age Einstein would probably "call on the best and the brightest minds in the world, whoever they are, and wherever they live, whichever country they call their home, to pool their knowledge and co-innovate to create a better world."
IFA Executive Director Jens Heithecker was hugely impressed by the level of innovation: "As the number of exhibitors has grown, so did the quality and quantity of innovations as well as the number of product premieres that were shown here in Berlin for the first time."
Global media attendance has gone up yet again; the journalists coming to Berlin work for media organisations covering 160 countries around the world. This shows how important IFA is in the calendar for technology and lifestyle journalists. This year, IFA attracted some 2.800 international journalists from around the world.
Among the broadcasters reporting from IFA Berlin were Al Jazeera from the Arab Emirates, NDTV from India, Nine Network from Australia, the BBC from the United Kingdom, IBA International from Israel, TEKNAVI from Finland, CNBC from the USA, CGTN / CCTV, Global Times as well as the Phoenix Group from China. From France teams from Eurosport, 01net TV, LCI, BFM TV, OUATCH.tv, France 24 and ES 1 reported on the latest IFA news. News agencies such as AP and Reuters were represented, alongside public broadcasters working through the EBU and private broadcasters cooperating through ENEX.
SHIFT – Future of Mobility
SHIFT, the two-day convention on how new technologies are shaping the Future of Mobility, has grown strongly compared to the previous year; among the speakers were top executives from industry giants such as AXA insurance, BMW, Daimler/Smart, Ford Fujitsu and Volkswagen, start-ups like 2Getthere, Iomob, LISNR, Trafi, Vive La Car, what3words and Wundermobility, and mobility pioneers like Zipcar Founder Robin Chase, the former CTO of Barcelona Francesca Bria, former Tata Motors CEO Venkat Sumantran, and a very unusual automotive consultant, Jay Ward the creative director of the Cars Franchise at Pixar Animation Studios.
IFA Global Markets
IFA Global Markets exclusively accessible to trade visitors, suppliers, manufacturers and OEMs / ODMs established itself as a significant part of IFA.
Dirk Koslowski
, IFA Director, states: "IFA Global Markets has been growing continuously for four years now. It is thus the leading platform in Europe for the supplier industry and has firmly established its position as the largest sourcing show in Europe."
Covering 20,000 square meters, the B2B marketplace IFA Global Markets was once again fully booked.
IFA Global Events – Save the Dates
CE China 2019
19 - 21 September, Guangzhou, China
CE Week 2020
10 - 11 June, New York, USA
IFA Global Press Conference 2020
2 - 5 April, Cyprus
IFA 2020
4 - 9 September
2 - 3 September, IFA Media Days
2 September, IFA Opening Press Conference, 1 p.m.
6 - 9 September IFA Global Markets
View source version on businesswire.com: https://www.businesswire.com/news/home/20190912005397/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom